Skip to main content
bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · Real-Time Price · USD
0.5120
+0.0173 (3.50%)
At close: Apr 24, 2025, 4:00 PM
0.5070
-0.0050 (-0.98%)
Pre-market: Apr 25, 2025, 6:07 AM EDT

bioAffinity Technologies Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
9.362.530--
Revenue Growth (YoY)
269.68%52627.44%---
Cost of Revenue
5.981.740--
Gross Profit
3.380.790--
Selling, General & Admin
9.946.792.481.070.99
Research & Development
1.781.721.521.141.61
Operating Expenses
12.338.764.022.212.6
Operating Income
-8.95-7.97-4.01-2.21-2.6
Interest Expense
-0.09-0.04-2.53-1-0.38
Interest & Investment Income
0.020.120.0500
Other Non Operating Income (Expenses)
0-0.03-1.87-3.36-4.28
EBT Excluding Unusual Items
-9.03-7.92-8.36-6.56-7.27
Other Unusual Items
--0.210.24-
Pretax Income
-9.03-7.92-8.15-6.32-7.27
Income Tax Expense
0.010.02000
Net Income
-9.04-7.94-8.15-6.33-7.27
Net Income to Common
-9.04-7.94-8.15-6.33-7.27
Shares Outstanding (Basic)
129433
Shares Outstanding (Diluted)
129433
Shares Change (YoY)
38.61%94.43%68.17%0.01%-
EPS (Basic)
-0.75-0.91-1.81-2.36-2.72
EPS (Diluted)
-0.75-0.91-1.81-2.36-2.72
Free Cash Flow
-7.34-6.06-4.29-2.05-2.21
Free Cash Flow Per Share
-0.61-0.69-0.95-0.77-0.83
Gross Margin
36.09%31.26%90.28%--
Operating Margin
-95.64%-314.84%-83511.51%--
Profit Margin
-96.56%-313.41%-169771.25%--
Free Cash Flow Margin
-78.44%-239.32%-89336.50%--
EBITDA
-8.35-7.72-4-2.2-2.58
EBITDA Margin
-89.17%----
D&A For EBITDA
0.610.250.0100.02
EBIT
-8.95-7.97-4.01-2.21-2.6
EBIT Margin
-95.64%----
Advertising Expenses
0.270.090.04--
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q